Literature DB >> 11926847

Plasma D-dimers in the diagnosis of venous thromboembolism.

James Kelly1, Anthony Rudd, Roger R Lewis, Beverley J Hunt.   

Abstract

Clinical suspicion for venous thromboembolism (VTE) mandates objective testing to confirm or exclude the diagnosis. However, current imaging modalities are imperfect because of a small but important risk of complications with invasive techniques or limited sensitivity with noninvasive ones. A diagnostic tool for VTE is needed that is noninvasive and highly accurate, allowing immediate treatment decisions to be made in most cases. Plasma D-dimers (D-ds), specific cross-linked fibrin derivatives, partially fulfill these criteria in that they are sensitive markers for thrombosis but lack specificity. They therefore cannot be used to make a positive diagnosis of VTE; however, they generally have high negative predictive value and are useful as an exclusionary test, a potentially important role given that VTE is eventually ruled out in most patients investigated. Clinical management studies are clarifying the role of D-ds in the diagnostic paradigm of VTE: negative ultrasound and D-d findings obviate the need for serial imaging in suspected deep vein thrombosis, and anticoagulant therapy can be safely withheld in patients with non-high clinical suspicion for pulmonary embolism and non-high probability ventilation perfusion scan if D-d test results are negative. More recently, the combination of a negative SimpliRED (AGEN Biomedical Ltd, Brisbane, Australia) D-d result and low clinical suspicion derived using a formal scoring system has been shown to exclude deep vein thrombosis and pulmonary embolism and to obviate the need for imaging. Several different D-d assays are now available, and clinicians should be aware of the performance characteristics of the test used before incorporation into diagnostic algorithms as these will differ between assays, and the results of clinical management studies cannot necessarily be safely extrapolated to assays other than those specifically evaluated. If alternative assays are to be substituted, these should consistently have been shown to possess equivalent or greater sensitivity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11926847     DOI: 10.1001/archinte.162.7.747

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  49 in total

Review 1.  Diagnosis, investigation, and management of deep vein thrombosis.

Authors:  Clive Tovey; Suzanne Wyatt
Journal:  BMJ       Date:  2003-05-31

2.  Managing pulmonary embolism.

Authors:  Karin Janata
Journal:  BMJ       Date:  2003-06-21

3.  ACCESS: the acute cerebral CT evaluation stroke study.

Authors:  J Wardlaw
Journal:  Emerg Med J       Date:  2004-11       Impact factor: 2.740

4.  Evaluation of the Simplify D-dimer assay as a screening test for the diagnosis of deep vein thrombosis in an emergency department.

Authors:  D Neale; C Tovey; A Vali; S Davies; K Myers; M Obiako; V Ramkumar; A Hafiz
Journal:  Emerg Med J       Date:  2004-11       Impact factor: 2.740

5.  Association between plasma levels of D-dimer and fibrinogen/fibrin degradation products (FDP) for exclusion of thromboembolic disorders.

Authors:  Rafael Noal Moresco; Ronald Halla Júnior; Luis Cláudio Rosa Vargas; Lúcia Mariano da Rocha Silla
Journal:  J Thromb Thrombolysis       Date:  2006-04       Impact factor: 2.300

6.  Mean platelet volume and D-dimer in patients with suspected deep venous thrombosis.

Authors:  Arzu Canan; Siddıka Sezgin Halıcioğlu; Safiye Gürel
Journal:  J Thromb Thrombolysis       Date:  2012-08       Impact factor: 2.300

7.  Lack of association between cardiac troponin T and D-dimer in the evaluation of myocardial damage.

Authors:  Rafael Noal Moresco; Luís Cláudio Rosa Vargas; Ronald Halla Júnior; Lúcia Mariano da Rocha Silla
Journal:  J Clin Lab Anal       Date:  2005       Impact factor: 2.352

Review 8.  Is the lung scan alive and well? Facts and controversies in defining the role of lung scintigraphy for the diagnosis of pulmonary embolism in the era of MDCT.

Authors:  John H Reid; Emmanuel E Coche; Tomio Inoue; Edmund E Kim; Maurizio Dondi; Naoyuki Watanabe; Giuliano Mariani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-01-27       Impact factor: 9.236

Review 9.  The challenges of managing cancer related venous thromboembolism in the palliative care setting.

Authors:  S Noble
Journal:  Postgrad Med J       Date:  2007-11       Impact factor: 2.401

Review 10.  Diagnosing pulmonary embolism.

Authors:  M Riedel
Journal:  Postgrad Med J       Date:  2004-06       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.